Effect of Danzhijiangtang capsule on monocyte chemoattractant protein-1 mRNA expression in newly diagnosed diabetes subclinical vascular lesions

World Journal of Gastroenterology

Volumn 19, Issue 19, 2013, Pages 2963-2968

  Fang, Zhao Hui ^a   Liu, Yan ^a   Bao, Tao Tao ^a   Ni, Ying Qun ^a   Liu, Jian ^a   Shi, Guo Bin ^a   Wu, Ji Ping ^a   Yang, Jun Ping ^b   Zhang, Hong ^c  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

^b Department of Gastroenterology   (China)

^c Wuhai Hospital of Traditional Chinese Medicine   (China)

Author keywords

Danzhijiangtang capsule; Monocyte chemoattractant protein 1; Subclinical vascular lesions; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; DANZHIJIANGTANG CAPSULE; GLICLAZIDE; GLUCOBA; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; KASIPING; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; ORAL ANTIDIABETIC AGENT; PADGEM PROTEIN; PIOGLITAZONE; REPAGLINIDE; THROMBOMODULIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CHINESE MEDICINE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC ANGIOPATHY; ELISA KIT; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SCORING SYSTEM;

EID: 84878100380     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i19.2963     Document Type: Article

References (25)

1. He Q, Luo HM, Tang XH, Zhu BS, Chen AB, Chen JY. The effects of blood glucose control on levels of monocyte chemoattractant protein-1 (MCP-1) activity in peripheral blood of patients with hyperglycemic crisis. Zhongguo Tangniaobing Zazhi 2012; 3: 216-218
2. Sakallioǧlu EE, Ayas B, Lütfioǧlu M, Keleş GC, Açikgöz G, Firatli E. Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: an experimental study in rats. Clin Oral Investig 2008; 12: 83-89 [PMID: 17876613]
3. Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsuhisa M, Kajimoto Y, Kosugi K, Shimizu Y, Kawamori R, Hori M. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 2000; 23: 1310-1315 [PMID: 10977024 DOI: 10.2337/diacare.23.9.1310]
4. Matsumoto K, Sera Y, Nakamura H, Ueki Y, Miyake S. Correlation between common carotid arterial wall thickness and ischemic stroke in patients with type 2 diabetes mellitus. Metabolism 2002; 51: 244-247 [PMID: 11833056]
5. Taniwaki H, Shoji T, Emoto M, Kawagishi T, Ishimura E, Inaba M, Okuno Y, Nishizawa Y. Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus. Atherosclerosis 2001; 158: 207-214 [PMID: 11500193 DOI: 10.1016/S0021-9150(01)00414-2]
6. Pechánová O, Simko F. The role of nitric oxide in the maintenance of vasoactive balance. Physiol Res 2007; 56 Suppl 2: S7-S16 [PMID: 17824812]
7. Zhang HF, Zhao ZG. Relations of adipocyte factors with type 2 diabetes and macrovascular lesions. Zhongguo Lingchuang Baojian Zazhi 2007; 1: 96-99
8. Lorenzi M. Glucose toxicity in the vascular complications of diabetes: the cellular perspective. Diabetes Metab Rev 1992; 8: 85-103 [PMID: 1425126 DOI: 10.1002/dmr.5610080202]
9. Szegedi N, May Z, Ováry C, Skopál J, Nagy Z. Molecular markers of endothelial dysfunction in acute ischemic stroke. Ideggyogy Sz 2002; 55: 102-108 [PMID: 12122979]
10. Borawski J, Myśliwiec M. Soluble thrombomodulin: a marker of endothelial injury, an antithrombotic agent, or both? Med Sci Monit 2001; 7: 785-786 [PMID: 11433212]
11. Kobayashi H, Sadakata H, Suzuki K, She MY, Shibata S, Terao T. Thrombomodulin release from umbilical endothelial cells initiated by preeclampsia plasma-induced neutrophil activation. Obstet Gynecol 1998; 92: 425-430 [PMID: 9721783 DOI: 10.1016/S0029-7844(98)00217-8]
12. Blann AD, Lip GY. Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997; 128: 135-138 [PMID: 9050769]
13. Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997; 34: 255-265 [PMID: 9205537 DOI: 10.1016/S0008-6363(97) 00039-4]
14. Yao W, Yang L, Chen TD, Li PJ, Ma YH. Study of P-selectin and cardiovascular risk. Zhongguo Jijiu Yixue 2002; 22: 18-20
15. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T, Ueki K, Oishi Y, Nishimura S, Manabe I, Hashimoto H, Ohnishi Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Nagai R, Kadowaki T. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 2006; 281: 26602-26614 [PMID: 16809344 DOI: 10.1074/ jbc.M601284200]
16. Lee SK, Kim BS, Yang WS, Kim SB, Park SK, Park JS. High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells. Kidney Int 2001; 60: 55-64 [PMID: 11422736 DOI: 10.1046/j.1523-1755.2001.00770.x]
17. Ehlermann P, Eggers K, Bierhaus A, Most P, Weichenhan D, Greten J, Nawroth PP, Katus HA, Remppis A. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovasc Diabetol 2006; 5: 6 [PMID: 16573830]
18. Zhan Y, Brown C, Maynard E, Anshelevich A, Ni W, Ho IC, Oettgen P. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 2005; 115: 2508-2516 [PMID: 16138193 DOI: 10.1172/JCI24403]
19. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 1995; 25 Suppl 2: S9-12 [PMID: 8699871 DOI: 10.1097/00005344-199500252-00003]
20. Utimura R, Fujihara CK, Mattar AL, Malheiros DM, Noronha IL, Zatz R. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 2003; 63: 209-216 [PMID: 12472785 DOI: 10.1046/ j.1523-1755.2003.00736.x]
21. Zhou XJ, Jiang LZ, Yang GM, Gong Y, Liu Y, Wang JZ, Zhu D, Qi G. The association of MCP-1 with type 2 diabetes and insulin resistance. Zhongguo Tangniaobing Zazhi 2008; 3: 152-153
22. Han KH, Ryu J, Hong KH, Ko J, Pak YK, Kim JB, Park SW, Kim JJ. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. Circulation 2005; 111: 1439-1447 [PMID: 15781755 DOI: 10.1161/01.CIR.0000158484.18024.1F]
23. He DC, Lin H, Cheng YH, Ding Xj. Effect of Chinese medicine compound on the expression of blood NF-κB and mRNA of MCP-1 in rats with diabetes. Xiandai Zhongxiyijiehe Zazhi 2009; 6: 1856-1858
24. Huang TT, Chen XW, Zhang P, He YB. Correlation between levels of serum MCP-1, IL-18 and carotid intima-media thickness in patients with type 2 diabetes. Linchuang Huicui 2010; 8: 654-657
25. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003; 107: 690-695 [PMID: 12578870 DOI: 10.1161/01.CIR.0000049742. 68848.99]